Amy Abernethy: Poised To Propel FDA Into Tech-Savvy, Patient-Centric Future [Forbes]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Forbes
FDA Commissioner Dr. Scott Gottlieb’s recently announced appointment of Dr. Amy Abernethy to serve as his first lieutenant perfectly exemplifies the sort of thinking that has enabled Gottlieb to earn nearly universal praise at a time of unprecedented partisanship. He has focused his attention on high-priority, immediate concerns like the targeting of e-cigarettes to children, the opioid epidemic, and the need for a more robust market in affordable generic medications, while also seeking to prepare the agency to engage with emerging technologies, from consumer wearables to applications of artificial intelligence, to expand the breadth of evidence generation and accelerate the speed of analysis. Amy Abernethy, MD, PhD, formerly Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Flatiron Health, and recently named Deputy Commissioner of the FDA. A. Abernethy Abernethy combines the pragmatic humanism of an oncologist (which she is) wi
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Xaira, an AI drug discovery startup, launches with a massive $1B, says it's ‘ready' to start developing drugs [TechCrunch]TechCrunch
- Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales [Yahoo! Finance]Yahoo! Finance
- Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Swiss pharmaceutical maker Roche says group sales dropped 6% [Yahoo! Finance]Yahoo! Finance
- Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology [Yahoo! Finance]Yahoo! Finance